March 31, 2009, 5:13 pm
National Blog Main, Seattle, Seattle Blog Main, Venture Capital, Private Equity, People, Ignition Partners, Ignition Capital, Brad Silverberg, Rich Tong, John Zagula, Jon Anderson, Cameron Myhrvold, Steve Hooper, Growth Stage Fund, Investors, Investing, Ignition Ventures
Venture Capital, Private Equity, people Gregory T. Huang wrote: Xconomy reported yesterday that Bellevue, WA-based Ignition Partners has split into separate management organizations with the formation of downtown Seattle-based Ignition Capital, which is focused on growth-stage and private equity investments. Reached by e-mail, Ignition
March 31, 2009, 3:51 pm
National Blog Main, San Diego, San Diego Blog Main, Innovation, Technology, Economy, Partnerships, Sweden, Innovation Bridge, People, Peter Str Mb Ck, Mary Walshok, Tomas Hagenfeldt
getting access to the international market at a suitable time. This will give them an opportunity to get help and support locally when they establish themselves there.” The San Diego site is expected to host representatives of Swedish technology companies for as long as a year, said Mary Walshok, a UC San Diego associate chancellor who
March 31, 2009, 10:13 am
Boston Blog Main, National, National Blog Main, Seattle Blog Main, Biotech, Cancer, Multiple Sclerosis, Genzyme, Life Sciences, Bayer, Immunex, Amgen, Leukine, Fludara, Campath, Henri Termeer
now a large company, it can maintain fast growth, with a stated goal of 20 percent compound annual earnings growth from 2006 through 2011. This acquisition of cancer drugs is supposed to provide an additional $185 million in revenue in 2009, and as much as $700 million in revenue over three years, which will help support the company’s
March 31, 2009, 10:07 am
National Blog Main, San Diego, San Diego Blog Main, Electronic Health Records, Genomics, Wireless, Life Sciences, Health Care, Personalized Medicine, Data Storage, Intel, Qualcomm, Google, Cisco Systems
Electronic Health Records, Genomics, wireless Bruce V. Bigelow wrote: While San Diego learned yesterday it is the new home of the nation’s first wireless health care research institute, a vision of the sweeping changes that such technologies pose was taking form in a UC San Diego conference room. The high-level meeting was organized
March 31, 2009, 9:28 am
Boston, Boston Blog Main, National Blog Main, Startups, Innovation, Google, Google Ventures, Rich Miner, Bill Maris, Android, Venture, Venture Capital, New England
calls the company’s domain knowledge—put it in a unique position to scout out and support innovative young companies in similar areas. The fund’s tactical approach, Miner and Maris wrote in last night’s blog post, will be to marry “the best practices of top-tier, financially focused venture capital firms” with
March 31, 2009, 6:00 am
Boston, Boston Blog Main, National Blog Main, Xconomy, Mobile, Events, Wireless, Forum, Forums, New England, Ambient Corporation, Enterprise Mobile, Everypoint, Fitnesskeeper, Runkeeper, Jumptap, Pongr, Pyxis Mobile, Skyhook Wireless, Vlingo
Xconomy, Mobile, IT Wade Roush wrote: On April 7, Xconomy will hold its first-ever Forum on the Future of Mobile Innovation in New England, an afternoon-long event designed to highlight the technologies and ideas that will lead the local mobile industry through—and past—the economic downturn. CEOs, engineers, analysts, and
March 31, 2009, 4:00 am
National Blog Main, Seattle, Seattle Blog Main, Biotech, Cancer, Drugs, Life Sciences, Oncothyreon, Bob Kirkman, Christopher Henney, Cell Genesys, Favrille, Genitope, Dendreon, Xcyte Therapies, Prolx Pharmaceuticals, Merck Kgaa, Stimuvax, Rodman Amp Renshaw, Simos Simeonidi
Biotech, cancer, Drugs Luke Timmerman wrote: Cancer vaccines still have the power to captivate the public imagination, but Bob Kirkman isn’t betting his company on them anymore. The CEO of Seattle-based Oncothyreon has reinvented this little biotech firm in a way that puts a pair of experimental cancer drugs, not vaccines, on the
March 31, 2009, 3:00 am
National Blog Main, Seattle, Seattle Blog Main, Roundup, Deals, Venture Capital, Pathway Medical, Biotech, Life Sciences, Medical Devices, Forbion Capital Partners, Hlm Venture Partners, Oxford Bioscience Partners, Latterell Capital, Cooperative Aac, Giza Venture Fun
$1.3 million grant from the National Science Foundation, as Luke reported. The funds will be used to help high school teachers and students understand how information technology is used in biomedical research. —Seattle-based Vulcan Capital, Paul Allen’s venture firm, invested in a $15 million Series D round of financing for Audience,
March 31, 2009, 2:00 am
Boston, Boston Blog Main, National Blog Main, San Diego Blog Main, Biotech, Gene Therapy, Life Sciences, Clinical Trials, Genzyme, Peripheral Artery Disease, American College Of Cardiology, Parkinson S Disease, Macular Degeneration, Hiv, Mark Creager, Brigham Amp Women
the cardiology meeting. The main goal of the trial, which began in 2005, was to see if the Genzyme treatment could increase the time patients could walk on an inclined treadmill before disabling pain or fatigue caused them to stop. Researchers examined patients after six months, and followed for them two years. Researchers saw that patients in
March 30, 2009, 5:21 pm
National Blog Main, Seattle, Seattle Blog Main, Energy, Innovation, Analysis, Events, Cascadia Capital, People, Michael Butler, Jesse Berst, Global Smart Energy, Jeremy Jaech, Verdiem, Linden Rhoads, Uw Tech Transfer, Mark Aggar, Microsoft, Venture Capital, Policy, Fundin
energy, innovation, Analysis Gregory T. Huang wrote: Last Thursday, we hosted a fantastic event on energy innovation at K&L Gates in downtown Seattle. The panel discussion—moderated by Michael Butler of Cascadia Capital and featuring Mark Aggar of Microsoft, Jesse Berst of Global Smart Energy, Jeremy Jaech of Verdiem, and Linden
